Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017 (2017), Article ID 4137626, 16 pages
https://doi.org/10.1155/2017/4137626
Clinical Study

Safety and Effectiveness of Bone Marrow Cell Concentrate in the Treatment of Chronic Critical Limb Ischemia Utilizing a Rapid Point-of-Care System

1TotipotentRX Centre for Cellular Medicine, Subsidiary of Cesca Therapeutics Inc., Gurgaon, India
2Geisel School of Medicine, Dartmouth-Hitchcock Medical Centre, Lebanon, NH, USA
3Fortis Escorts Heart Institute and Research Centre, New Delhi, India

Correspondence should be addressed to Venkatesh Ponemone; moc.liamg@enomenop

Received 22 July 2016; Accepted 14 December 2016; Published 17 January 2017

Academic Editor: Thomas Ichim

Copyright © 2017 Venkatesh Ponemone et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Teraa, M. S. Conte, F. L. Moll, and M. C. Verhaar, “Critical limb ischemia: current trends and future directions,” Journal of the American Heart Association, vol. 5, no. 2, Article ID e002938, 2016. View at Publisher · View at Google Scholar
  2. M. H. Shishehbor, C. J. White, B. H. Grey et al., “Critical limb ischemia: an expert statement,” Journal of the American College of Cardiology, vol. 68, no. 18, pp. 2002–2015, 2016. View at Google Scholar
  3. A. Schiavetta, C. Maione, C. Botti et al., “A phase II trial of autologous transplantation of bone marrow stem cells for critical limb ischemia: results of the Naples and Pietra Ligure evaluation of stem cells study,” Stem Cells Translational Medicine, vol. 1, no. 7, pp. 572–578, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. F. J. Serrano Hernando and A. M. Conejero, “Peripheral artery disease: pathophysiology, diagnosis and treatment,” Revista Espanola de Cardiologia, vol. 60, no. 9, pp. 969–982, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. A. T. Hirsch, M. H. Criqui, D. Treat-Jacobson et al., “Peripheral arterial disease detection, awareness, and treatment in primary care,” Journal of the American Medical Association, vol. 286, no. 11, pp. 1317–1324, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Bartsch, M. Brehm, T. Zeus, and B.-E. Strauer, “Autologous mononuclear stem cell transplantation in patients with peripheral occlusive arterial disease,” Journal of Cardiovascular Nursing, vol. 21, no. 6, pp. 430–432, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. T. E. Thorgeirsson, F. Geller, P. Sulem et al., “A variant associated with nicotine dependence, lung cancer and peripheral arterial disease,” Nature, vol. 452, no. 7187, pp. 638–642, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A. M. Wilson, A. H. Sadrzadeh-Rafie, J. Myers et al., “Low lifetime recreational activity is a risk factor for peripheral arterial disease,” Journal of Vascular Surgery, vol. 54, no. 2, pp. 427–432, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. G. P. Fadini, C. Agostini, and A. Avogaro, “Autologous stem cell therapy for peripheral arterial disease. Meta-analysis and systematic review of the literature,” Atherosclerosis, vol. 209, no. 1, pp. 10–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. S. Conte, P. J. Geraghty, A. W. Bradbury et al., “Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia,” Journal of Vascular Surgery, vol. 50, no. 6, pp. 1462.e3–1473.e3, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. W. A. Marston, S. W. Davies, B. Armstrong et al., “Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization,” Journal of Vascular Surgery, vol. 44, no. 1, pp. 108.e1–114.e1, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. N. K. Gupta, E. J. Armstrong, and S. A. Parikh, “The current state of stem cell therapy for peripheral artery disease,” Current Cardiology Reports, vol. 16, article no. 447, 2014. View at Publisher · View at Google Scholar
  13. Y. Tachi, D. Fukui, Y. Wada et al., “Changes in angiogenesis-related factors in serum following autologous bone marrow cell implantation for severe limb ischemia,” Expert Opinion on Biological Therapy, vol. 8, no. 6, pp. 705–712, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Amann, C. Luedemann, R. Ratei, and J. A. Schmidt-Lucke, “Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease,” Cell Transplantation, vol. 18, no. 3, pp. 371–380, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Molavi, M. R. Zafarghandi, E. Aminizadeh et al., “Safety and efficacy of repeated bone marrow mononuclear cell therapy in patients with critical limb ischemia in a pilot randomized controlled trial,” Archives of Iranian Medicine, vol. 19, no. 6, pp. 388–396, 2016. View at Google Scholar · View at Scopus
  16. T. W. Liang, A. Jester, R. L. Motaganahalli et al., “Autologous bone marrow mononuclear cell therapy for critical limb ischemia is effective and durable,” Journal of Vascular Surgery, vol. 63, no. 6, pp. 1541–1545, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Norgren, W. R. Hiatt, J. A. Dormandy, M. R. Nehler, K. A. Harris, and F. G. R. Fowkes, “Inter-society consensus for the management of peripheral arterial disease (TASC II),” European Journal of Vascular and Endovascular Surgery, vol. 33, no. 1, supplement, pp. S1–S75, 2007. View at Publisher · View at Google Scholar
  18. H. Lawall, P. Bramlage, and B. Amann, “Stem cell and progenitor cell therapy in peripheral artery disease: a critical appraisal,” Thrombosis and Haemostasis, vol. 103, no. 4, pp. 696–709, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Asahara, T. Murohara, A. Sullivan et al., “Isolation of putative progenitor endothelial cells for angiogenesis,” Science, vol. 275, no. 5302, pp. 964–967, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. Q. Shi, S. Rafii, M.-D. Wu et al., “Evidence for circulating bone marrow-derived endothelial cells,” Blood, vol. 92, pp. 362–367, 1998. View at Google Scholar
  21. E. Tateishi-Yuyama, H. Matsubara, T. Murohara et al., “Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial,” Lancet, vol. 360, no. 9331, pp. 427–435, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Hernández, L. Cortina, H. Artaza et al., “Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation,” Atherosclerosis, vol. 194, no. 2, pp. e52–e56, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Wester, J. J. Jørgensen, E. Stranden et al., “Treatment with autologous bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot study,” Scandinavian Journal of Surgery, vol. 97, no. 1, pp. 56–62, 2008. View at Google Scholar · View at Scopus
  24. R. W. Franz, A. Parks, K. J. Shah, T. Hankins, J. F. Hartman, and M. L. Wright, “Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease,” Journal of Vascular Surgery, vol. 50, no. 6, pp. 1378–1390, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. R. W. Sprengers, F. L. Moll, M. Teraa, and M. C. Verhaar, “Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia,” Journal of Vascular Surgery, vol. 51, no. 6, pp. 1564–1568, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Idei, J. Soga, T. Hata et al., “Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and buerger disease,” Circulation: Cardiovascular Interventions, vol. 4, no. 1, pp. 15–25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Gabr, A. Hedayet, U. Imam, and M. Nasser, “Limb salvage using intramuscular injection of unfractionated autologous bone marrow mononuclear cells in critical limb ischemia: a prospective pilot clinical trial,” Experimental and Clinical Transplantation, vol. 9, no. 3, pp. 197–202, 2011. View at Google Scholar · View at Scopus
  28. Z.-X. Wang, D. Li, J.-X. Cao et al., “Efficacy of autologous bone marrow mononuclear cell therapy in patients with peripheral arterial disease,” Journal of Atherosclerosis and Thrombosis, vol. 21, no. 11, pp. 1183–1196, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. R. J. Powell, A. J. Comerota, S. A. Berceli et al., “Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia,” Journal of Vascular Surgery, vol. 54, no. 4, pp. 1032–1041, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. M. R. Finney, N. J. Greco, S. E. Haynesworth et al., “Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia,” Biology of Blood and Marrow Transplantation, vol. 12, no. 5, pp. 585–593, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. S. A. Choksy and P. Chan, “Therapeutic angiogenesis,” British Journal of Surgery, vol. 93, no. 3, pp. 261–263, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. C. V. Lalithambika, B. Nisha, L. Saraswathy et al., “Ankle brachial index and transcutaneous partial pressure of oxygen as predictors of wound healing in diabetic foot ulcers,” The Journal of Diabetic Foot Complications, vol. 6, no. 2, pp. 54–59, 2014. View at Google Scholar
  33. I. R. McPhail, L. T. Cooper, D. O. Hodge, M. E. Cabanela, and T. W. Rooke, “Transcutaneous partial pressure of oxygen after surgical wounds,” Vascular Medicine, vol. 9, no. 2, pp. 125–127, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. J. G. Kilian, A. Keech, M. R. Adams et al., “Coronary collateralization: determinants of adequate distal vessel filling after arterial occlusion,” Coronary Artery Disease, vol. 13, no. 3, pp. 155–159, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Wahlberg, “Angiogenesis and arteriogenesis in limb ischemia,” Journal of Vascular Surgery, vol. 38, no. 1, pp. 198–203, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. C. L. Cetrulo Jr., K. R. Knox, D. J. Brown et al., “Stem cells and distraction osteogenesis: endothelial progenitor cells home to the ischemic generate in activation and consolidation,” Plastic and Reconstructive Surgery, vol. 116, no. 4, pp. 1053–1064, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. S. De Vivo, U. Palmer-Kazen, B. Kalin, and E. Wahlberg, “Risk factors for poor collateral development in claudication,” Vascular and Endovascular Surgery, vol. 39, no. 6, pp. 519–524, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. J.-S. Silvestre, D. M. Smadja, and B. I. Lévy, “Post-ischemic revascularization: from cellular and molecular mechanisms to clinical applications,” Physiological Reviews, vol. 93, no. 4, pp. 1743–1802, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Sampson, A. Botto-van Bemden, and D. Aufiero, “Autologous bone marrow concentrate: review and application of a novel intra-articular orthobiologic for cartilage disease,” The Physician and sportsmedicine, vol. 41, no. 3, pp. 7–18, 2013. View at Google Scholar · View at Scopus
  40. R. Compagna, B. Amato, S. Massa et al., “Cell therapy in patients with critical limb ischemia,” Stem Cells International, vol. 2015, Article ID 931420, 13 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Benoit, T. F. O'Donnell Jr., M. D. Iafrati et al., “The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design,” Journal of Translational Medicine, vol. 9, no. 1, article 165, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Botti, C. Maione, A. Coppola, V. Sica, and G. Cobellis, “Autologous bone marrow cell therapy for peripheral arterial disease,” Stem Cells and Cloning: Advances and Applications, vol. 5, no. 1, pp. 5–14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. E. C. Perin, G. Silva, A. Gahremanpour et al., “A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia,” Catheterization and Cardiovascular Interventions, vol. 78, no. 7, pp. 1060–1067, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Kinnaird, E. S. Burnett, M. Shou et al., “local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms,” Circulation, vol. 109, no. 12, pp. 1543–1549, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Klepanec, M. Mistrik, C. Altaner et al., “No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia,” Cell Transplantation, vol. 21, no. 9, pp. 1909–1918, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Sinno and S. Prakash, “Complements and the wound healing cascade: an updated review,” Plastic Surgery International, vol. 2013, Article ID 146764, 7 pages, 2013. View at Publisher · View at Google Scholar
  47. S. Matoba, T. Tatsumi, T. Murohara et al., “Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia,” American Heart Journal, vol. 156, no. 5, pp. 1010–1018, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. V. Motukuru, K. R. Suresh, V. Vivekanand, S. Raj, and K. R. Girija, “Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells,” Journal of Vascular Surgery, vol. 48, no. 6, pp. S53–S60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Gupta and D. W. Losordo, “Cell therapy for critical limb ischemia: moving forward one step at a time,” Circulation: Cardiovascular Interventions, vol. 4, no. 1, pp. 2–5, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. S. M. O. Peeters Weem, M. Teraa, G. J. de Borst, M. C. Verhaar, and F. L. Moll, “Bone marrow derived cell therapy in critical limb ischemia: a meta-analysis of randomized placebo controlled trials,” European Journal of Vascular and Endovascular Surgery, vol. 50, no. 6, pp. 775–783, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Teraa, R. W. Sprengers, R. E. G. Schutgens et al., “Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb Ischemia: the randomized, double-blind, placebo-controlled rejuvenating endothelial progenitor cells via transcutaneous intra-arterial supplementation (JUVENTAS) trial,” Circulation, vol. 131, no. 10, pp. 851–860, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. D. H. Walter, H. Krankenberg, J. O. Balzer et al., “Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia a randomized-start, placebo-controlled pilot trial (PROVASA),” Circulation: Cardiovascular Interventions, vol. 4, no. 1, pp. 26–37, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. P. K. Gupta, A. Chullikana, R. Parakh et al., “A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia,” Journal of Translational Medicine, vol. 11, no. 1, article 143, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. A. N. Raval, E. G. Schmuck, G. Tefera et al., “Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial,” Cytotherapy, vol. 16, no. 12, pp. 1720–1732, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. Y.-Q. Gu, J. Zhang, L.-R. Guo et al., “Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia,” Chinese Medical Journal, vol. 121, no. 11, pp. 963–967, 2008. View at Google Scholar · View at Scopus
  56. A. Ozturk, Y. Kucukardali, F. Tangi et al., “Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia,” Journal of Diabetes and Its Complications, vol. 26, no. 1, pp. 29–33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Huang, S. Li, M. Han, Z. Xiao, R. Yang, and Z. C. Han, “Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes,” Diabetes Care, vol. 28, no. 9, pp. 2155–2160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. C. Napoli, B. Farzati, V. Sica et al., “Beneficial effects of autologous bone marrow cell infusion and antioxidants/L-arginine in patients with chronic critical limb ischemia,” European Journal of Cardiovascular Prevention and Rehabilitation, vol. 15, no. 6, pp. 709–718, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. G. P. Lasala, J. A. Silva, P. A. Gardner, and J. J. Minguell, “Combination stem cell therapy for the treatment of severe limb ischemia: safety and efficacy analysis,” Angiology, vol. 61, no. 6, pp. 551–556, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. Fujita and A. Kawamoto, “Cell-based therapies for peripheral arterial disease,” Journal of Stem Cell Research & Therapy, vol. 4, article 234, 2014. View at Publisher · View at Google Scholar
  61. R. J. Powell, M. Simons, F. O. Mendelsohn et al., “Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia,” Circulation, vol. 118, no. 1, pp. 58–65, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. E. Faglia, G. Clerici, M. Caminiti, A. Quarantiello, V. Curci, and A. Morabito, “Predictive values of transcutaneous oxygen tension for above-the-ankle amputation in diabetic patients with critical limb ischemia,” European Journal of Vascular and Endovascular Surgery, vol. 33, no. 6, pp. 731–736, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. G. Cobellis, A. Silvestroni, S. Lillo et al., “Long-term effects of repeated autologous transplantation of bone marrow cells in patients affected by peripheral arterial disease,” Bone Marrow Transplantation, vol. 42, no. 10, pp. 667–672, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. M. M. McDermott, P. A. Ades, A. Dyer, J. M. Guralnik, M. Kibbe, and M. H. Criqui, “Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease,” Journal of Vascular Surgery, vol. 48, no. 5, pp. 1231–1237.e1, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. G. Dragneva, P. Korpisalo, and S. Ylä-Herttuala, “Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success,” Disease Models & Mechanisms, vol. 6, no. 2, pp. 312–322, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. N. J. Leeper, A. L. Hunter, and J. P. Cooke, “Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells,” Circulation, vol. 122, no. 5, pp. 517–526, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. K. S. Volz, E. Miljan, A. Khoo, and J. P. Cooke, “Development of pluripotent stem cells for vascular therapy,” Vascular Pharmacology, vol. 56, no. 5-6, pp. 288–296, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. P. Carmeliet, “Angiogenesis in health and disease,” Nature Medicine, vol. 9, no. 6, pp. 653–660, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. H.-S. Hung, W.-C. Shyu, C.-H. Tsai, S.-H. Hsu, and S.-Z. Lin, “Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases,” Cell Transplantation, vol. 18, no. 9, pp. 1003–1012, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. B. Heissig, K. Hattori, S. Dias et al., “Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand,” Cell, vol. 109, no. 5, pp. 625–637, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Sahoo, E. Klychko, T. Thorne et al., “Exosomes from human CD34+ stem cells mediate their proangiogenic paracrine activity,” Circulation Research, vol. 109, no. 7, pp. 724–728, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. R. J. Scheubel, J. Holtz, I. Friedrich et al., “Paracrine effects of CD34 progenitor cells on angiogenic endothelial sprouting,” International Journal of Cardiology, vol. 139, no. 2, pp. 134–141, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. V. Iyer, I. Klebba, J. McCready et al., “Estrogen promotes ER-negative tumor growth and angiogenesis through mobilization of bone marrow-derived monocytes,” Cancer Research, vol. 72, no. 11, pp. 2705–2713, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Teraa, R. W. Sprengers, P. E. Westerweel et al., “Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients,” PLOS ONE, vol. 8, no. 1, Article ID e55592, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. C.-H. Yoon, M. Koyanagi, K. Iekushi et al., “Mechanism of improved cardiac function after bone marrow mononuclear cell therapy: role of cardiovascular lineage commitment,” Circulation, vol. 121, no. 18, pp. 2001–2011, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. J. K. Willmann, B. Baumert, T. Schertler et al., “Aortoiliac and lower extremity arteries assessed with 16-detector row CT angiography: prospective comparison with digital subtraction angiography,” Radiology, vol. 236, no. 3, pp. 1083–1093, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. O. K. Qenawy, W. H. Tantawy, A. K. H. Abdalla, and S. A. A. Sayed, “Comparative study between multi-detector CT angiography and digital subtraction angiography in evaluation of peripheral arterial occlusive disease,” The Egyptian Journal of Radiology and Nuclear Medicine, vol. 46, pp. 1003–1010, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. H. Ota, K. Takase, K. Igarashi et al., “MDCT compared with digital subtraction angiography for assessment of lower extremity arterial occlusive disease: importance of reviewing cross-sectional images,” American Journal of Roentgenology, vol. 182, no. 1, pp. 201–209, 2004. View at Publisher · View at Google Scholar · View at Scopus
  79. M. D. Iafrati, J. W. Hallett, G. Geils et al., “Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia,” Journal of Vascular Surgery, vol. 54, no. 6, pp. 1650–1658, 2011. View at Publisher · View at Google Scholar · View at Scopus